Chickenpox vaccine safety study for healthy toddlers
Treatments studied
Part of Infections clinical trials.
This study tests a new chickenpox vaccine for healthy children ages 12 to 15 months. It aims to see if the vaccine is safe and helps protect against chickenpox.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 12 to 15 months old.
- Your child must be in good general health.
- Your child must not have had chickenpox or the chickenpox vaccine before.
- Your child must not have received the MMR, hepatitis A, or chickenpox vaccines yet.
- Your child must not have a weakened immune system or live with someone who is at high risk (like a pregnant woman without chickenpox history or a very young baby).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new chickenpox vaccine combined with a standard MMR vaccine (measles, mumps, rubella) in healthy children aged 12-15 months. The goal is to see how well the vaccines work and how safe they are when given as a shot in the arm.
This study tests an experimental chickenpox vaccine to see how well it works and if it's safe. Your child may be able to join if they are healthy and between 12 and 15 months old.
This study tests how well a second dose of an investigational chickenpox vaccine works and how safe it is in healthy children. Your child would get the first dose between 12-15 months old, then a booster 3 months later.
This study tests a chickenpox (varicella) vaccine in healthy children to see how well it works and if it is safe. It may help protect your child from chickenpox.
This study tests a chickenpox vaccine in healthy children. It aims to see if a lower dose of the vaccine is as effective and safe as the standard dose. Your child may be able to join if they have never had chickenpox or the vaccine.
This study tests a new chickenpox vaccine (MG1111, also called BARYCELA Inj.) in healthy children aged 1 to 12 years. It checks how well the vaccine works and if it is safe, with two doses given over time.
Hear when a new Chickenpox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.